Omar F. Khan
Also known as: Omar Khan
University of Toronto, Independent Consultant, Tiba Biotech
About
My name is Omar F. Khan from the University of Toronto. I am the Canada Research Chair in Nucleic Acid Therapeutics, an Assistant Professor in the Institute of Biomedical Engineering, and a cross-appointed Assistant Professor in the Faculty of Medicine's Department of Immunology. I am also a Medicine by Design Investigator. My research lab creates nucleic acids medicines for disease prevention and treatment. Azane Therapeutics is the first spinout from my lab.
Previously, I was a Postdoctoral Associate in the labs of Professors Robert Langer and Daniel Anderson at the Massachusetts Institute of Technology. I was the Scientific Founder and former Chief Scientist of Tiba Biotech, a RNA vaccine company spun out from my postdoctoral research. I earned my undergraduate and doctoral degrees in Chemical Engineering and Applied Chemistry from the University of Toronto with Professor Michael Sefton.
Employment
-
University of Toronto Assistant Professor2020 - Present
-
University of Toronto Assistant Professor2020 - Present
-
Independent Consultant Chemistry, manufacturing and control consultant2019 - Present
-
Tiba Biotech Founder & Chief Scientist2018 - 2019
-
Massachusetts Institute of Technology Research Scientist2016 - 2017
-
Massachusetts Institute of Technology Postdoctoral Associate2011 - 2017
Education
-
University of Toronto Ph.D2006 - 2011
-
University of Toronto M.A.Sc.2004 - 2006
-
University of Toronto B.A.Sc.1999 - 2004
Projects & Funding
Projects & funding information is unavailable.
Publications (53)
- Human and mouse long noncoding RNAs re-engineered for exogenous delivery reduce LPS-induced inflammation in human macrophages and mice Save
- PEG-Grafted Oligolysines Stabilize DNA Origami While Enhancing Receptor-Specific Cell Binding Save
- A Cell-Free Kinetic Analysis of Ionizable Lipid Hydrolysis Save
- Engineering ionizable lipids for rapid biodegradation balances mRNA vaccine efficacy and tolerability Save
- Ionizable Lipid with Supramolecular Chemistry Features for RNA Delivery In Vivo Save
- Best practices for characterizing RNA lipid nanoparticles Save
- Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery Save
- The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids Save
- Nucleic acid delivery differences across species Save
- Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche Save